Guidelines
Below you can find all of the clinical guidelines and pathways involving medicines which are approved for use across the North East and North Cumbria ICS.
For legacy guidelines you may still need to visit the previous APC websites until a single NENC ICB version is available.
| Title | Documents | Decision | Date | |
|---|---|---|---|---|
Cardiovascular |
||||
| NENC Patient Specific Factors to Consider When Choosing a DOAC in NVAF | NENC Decision Aid incl Table to support decison of DOAC - approved June 2022 (extended to June 2024) | Approved by NTAG | 20/06/2023 | |
|
Updated 02/11/2023 |
Northern England Evaluation and Lipid Intensification guideline | NEELI v2023.1.1 final | Approved by NENC Medicines Subcommittee | 17/10/2023 |
Respiratory |
||||
|
New 02/11/2023 |
NENC At A Glance Supporting Greener Respiratory Care | NENC At A Glance Supporting Greener Respiratory Care v2 FINAL | Approved | 17/10/2023 |
|
New 02/11/2023 |
NENC Mucolytics in adults consensus guide | NENC Mucolytics in Adults Consensus Guide v1.7 | Approved | 17/10/2023 |
Endocrine |
||||
|
Updated 02/11/2023 |
North East Guideline For Use Of Sodium Glucose Co transporter 2 Inhibitors (SGLT2i) | NENC regional SGLT2 top tips v1.2 - NTAG approved March 2023 v2 UPDATE June 2023 | Approved by NENC Medicines Subcommittee | 17/10/2023 |
|
Updated 02/11/2023 |
NENC Medication Management for Type 2 Diabetes in Adults Guidelines | NENC Regional T2DM Guidelines FINAL v2 JUNE 2023 | Approved by NENC Medicines Subcommittee | 17/10/2023 |
| Northern Region Gender Dysphoria Service - General Guidelines For The Use Of Hormone Treatment In Gender Dysphoria | This guideline is not endorsed by NTAG or the NENC Medicines Subcommittee. Instead the link to the document on the CNTW website is included here for ease of access for those who wish to refer to it. https://www.cntw.nhs.uk/wp-content/uploads/2022/04/FINAL-Hormone-Guidance-Mar-2021-V2-18.08.pdf | 17/10/2023 | ||
|
New 06/11/2023 |
NENC ICB - Management of the Menopause | NENC-Menopause-guidance-word-FINAL APPROVED - Oct 2023 | Approved by NENC Medicines Subcommittee | 17/10/2023 |
Obstetrics, gynaecology, and urinary tract infections |
||||
| Management of Symptomatic Recurrent Uncomplicated Urinary Tract Infections in Adult Women | recurrent-uti-ics-final-guidance-february-2023 | Approved | 21/02/2023 | |
Renal |
||||
| SGLT2-inhibitors and Chronic Kidney Disease - Patient Information Leaflet | SGLT2 CKD PIL NTAG v1 | Approved by NTAG | 07/06/2022 | |
Miscellaneous |
||||
|
New 02/11/2023 |
Abnormal Liver blood test Guidelines NENC Hepatology Network V2.2 | Abnormal Liver blood test Guidelines NENC Hepatology Network V2.2.1 10-7-2023 | Approved for hosting on NTAG website. | 17/10/2023 |
| NENC Penicillin Allergy Assessment Oral Challenge and De-labelling Secondary Care - June 2023 | NENC Penicillin Allergy Assessment Oral Challenge and De-labelling Secondary Care - June 2023 | Approved by NENC Medicines Subcommittee | 20/06/2023 |